Autopsy report · NCT01338935

Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Pharmacokinetic stopping criteria for the study were met.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 6 months before it stopped.
136 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Weill Medical College of Cornell University
Sponsor type: University, hospital or other
Conditions: Healthy
Interventions: CW 002; CW 002; CW 002
Participants: 136
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.